Health
COVID-19 vaccine candidate is 96.4 percent effective in mice, study shows – Drug Target Review
Administering two doses of a COVID-19 vaccine called BVX-0320 is effective in mouse models, a pre-clinical study has shown.
Posted: 1 December 2020 | Victoria Rees (Drug Target Review) | No comments yet
Administering two doses of a COVID-19 vaccine called BVX-0320 is effective in mouse models, a pre-clinical study has shown.
A new COVID-19 vaccine candidate has shown success in mouse models by inducing high levels of antibodies against the S1 fragment of the SARS-CoV-2 Spike (S) protein.
Developed by BioVaxys Technology, the vaccine, called BVX-0320, did not produce any toxicity in the mice. According to the researchers,…
-
Noosa News24 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News22 hours agoDefence investigation finds Taipan pilot’s actions possibly prevented further fatalities in crash
-
Noosa News22 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
General20 hours agoDairy farmers devastated by floods across parts of New South Wales